Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy - PubMed
3 hours ago
- #follicular lymphoma
- #immunochemotherapy
- #prognosis
- A short diagnosis-to-treatment interval independently predicts worse outcomes in follicular lymphoma patients treated with immunochemotherapy.
- The finding is based on international discovery and validation cohorts.
- This interval has prognostic value beyond established prognostic indices, affecting risk stratification, clinical trial design, and interpretation.